Santa Clarita Personal Injury Lawyer - FDA & Prescription Drugs

FDA Expands Face Paint Recalled to Include Yellow and White

Susy Owen — Tue, 26 May 2009 21:35:16 GMT

The U.S. Food and Drug Administration announced the expanded recall of China-manufactured face paint items to include two additional colors.

Fun Express Inc., has expanded its May 12 recall of the products to include white and yellow paints. The paints cause skin irritation, rashes and itchiness.

All paiants were manufactured by Shanghai Color Art Stationery Company Ltd. of Shanghai, and unopened packages of the face paint can be identified by a tube printed with the words "Water-Based Face Paint Net Weight 1 oz. (28.3gm) Non-Toxic Made in China."

The tube is on a cardboard backing with the words "Face Paint" on the front of the package and an item number in the upper right-hand corner of the backing. Directions for use, ingredients and "Distributed by Oriental Trading Co., Omaha, NE 68127" are also printed on the backing, the company said

The products were distributed nationwide.

Consumers with questions can contact Fun Express at 888-999-0442.

Originally posted at InjuryBoard by Susy Owen

Psoriasis Drug Raptiva Linked to Rare Brain Infection

Susy Owen — Wed, 25 Feb 2009 19:04:00 GMT

The FDA is strongly recommending that doctors closely monitor their patients currently taking Raptiva while also monitoring those that have taken the medication in the past. According to reports from the FDA, it has received three confirmed cases and one possible case of a rare brain infection known as progressive multifocal leukoencephalopathy (PML). Two of the reported PML patients have died and one with possible PML has died. All of the patients had been taking the drug for three years.

Raptiva is used for the treatment of moderate to severe plaque psoriasis. The unfortunate side effect is that it also affects the T-cells of the immune system leaving patients susceptible to infections.

PML is a rare, serious, progressive neurologic disease caused by a virus that affects the central nervous system. Symptoms of the infection indicated by the FDA are weakness, blurred vision and difficulty speaking. When PML occurs, it is usually in people whose immune systems have been severely weakened and often results in an irreversible decline in neurologic function and death. There is no known effective treatment for PML.

In October, 2008, a black box warning (the most significant warning that can be given to a drug) was added addressing the risk of contracting certain life-threatening infections while taking Raptiva, including PML. While the European Union's equivalent of the FDA immediately recommended that the drug be withdrawn from the European market, the FDA continues to investigate whether the risks of the drug outweigh the benefits.

Originally posted at InjuryBoard by Susy Owen

Voluntary Nationwide Recall of Prescription Prenatal Vitamins and Iron Supplements

Susy Owen — Fri, 06 Feb 2009 16:38:21 GMT

Ther-Rx Corporation issued a voluntary nationwide recall of prescription prenatal and iron supplement nutritionals at a wholesale level. According to the FDA website, the products may have been manufactured under conditions that did not sufficiently comply with current Good Manufacturing Practice (cGMP).

If you believe that you may posess the recalled product, do not discontinue use. Please consult your healthcare provider.

The complete list of recalled product includes:

Prescription Iron Supplement Products:

Chromagen® Caplet
Chromagen® FA Caplet
Chromagen® Forte Caplet
Encora® Capsule
Niferex® Gold Tablet
Niferex® 150 Forte Capsule
Repliva 21/7® Tablet

Prescription Prenatal Vitamin Products:

PreCare® Chewable Tablet
PreCare® Conceive Tablet
PreCare Premier® Tablet
PremesisRx® Tablet
PrimaCare® Capsule/Tablet
PrimaCare® Advantage™ Capsule/Tablet
PrimaCare® ONE Capsule

Originally posted at InjuryBoard by Susy Owen